Evolution of the Average Target: Cardinal Health, Inc.

Evolution of the Target Price: Cardinal Health, Inc.

Changes in Analyst Recommendations: Cardinal Health, Inc.

2a9d48f6b1d067fb9.8F5UAy54t4nIHNdeyf14nEO2GNeKkND0SQ_8XWleySo.um0XQHo05NOPK6McoZsWySncYI7O4JKzBGWOLzNrg2iVGA13Zxb_wJ1v7w~328bd2e185851b32e359cef4cbd120e3
06:53am Mizuho Adjusts Price Target on Cardinal Health to $240 From $235, Maintains Outperform Rating MT
06:52am Citigroup Adjusts Price Target on Cardinal Health to $265 From $245, Maintains Buy Rating MT
07-22 Baird Adjusts Price Target on Cardinal Health to $251 From $248, Maintains Outperform Rating MT
07-20 UBS Adjusts Price Target on Cardinal Health to $274 From $260, Maintains Buy Rating MT
07-09 TD Cowen Adjusts Price Target on Cardinal Health to $275 From $255 MT
07-07 Evercore ISI Adjusts Price Target on Cardinal Health to $265 From $240 MT
07-02 BofA Securities Adjusts Cardinal Health Price Target to $260 From $240 MT
06-12 William O'Neil Initiates Cardinal Health at Buy MT
05-04 U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower RE
05-01 TD Cowen Adjusts Price Target on Cardinal Health to $255 From $251 MT
05-01 Wells Fargo Adjusts Price Target on Cardinal Health to $245 From $256 MT
05-01 Baird Adjusts Price Target on Cardinal Health to $248 From $257 MT
05-01 Citigroup Adjusts Price Target on Cardinal Health to $245 From $249 MT
05-01 Analyst recommendations: Apple, ConocoPhillips, Stryker Corporation, Parker-Hannifin, Equinix Zonebourse
04-28 Morgan Stanley Adjusts Cardinal Health Price Target to $255 From $245, Maintains Overweight Rating MT
04-28 William Blair Initiates Cardinal Health at Outperform MT
04-08 Evercore ISI Adjusts Price Target on Cardinal Health to $240 From $260, Maintains Outperform Rating MT
03-19 Baird Adjusts Price Target on Cardinal Health to $257 From $252, Maintains Outperform Rating MT
03-02 Leerink Partners Adjusts Price Target on Cardinal Health to $275 From $268, Maintains Outperform Rating MT
02-23 Barclays Adjusts Cardinal Health Price Target to $258 From $243, Maintains Overweight Rating MT
02-11 TD Cowen Adjusts Price Target on Cardinal Health to $251 From $233, Maintains Buy Rating MT
02-11 Argus Research Adjusts Cardinal Health Price Target to $248 From $232, Maintains Buy Rating MT
02-10 Wells Fargo Adjusts Price Target on Cardinal Health to $256 From $237, Maintains Overweight Rating MT
02-10 JPMorgan Adjusts Price Target on Cardinal Health to $243 From $209, Maintains Neutral Rating MT
02-06 UBS Adjusts Cardinal Health Price Target to $260 From $250, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.69%
+15.69%
+15.34%
+23.27%
+52.98%
+33.81%
+11.81%
- -2.57%
+15.81%
+1.39%
Average +18.12%
Weighted average by Cap. +16.61%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
220.54USD
Average target price
250.73USD
Spread / Average Target
+13.69%
High Price Target
275.00USD
Spread / Highest target
+24.69%
Low Price Target
215.00USD
Spread / Lowest Target
-2.51%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
UBS
TD Cowen
Evercore ISI
BofA Securities
William O'Neil & Co
Wells Fargo Securities
Citigroup
Morgan Stanley
William Blair & Co.
Leerink Partners
Barclays
Argus
JPMorgan Chase
Mizuho Securities
Jefferies & Co.
Deutsche Bank Securities
Nephron Research
Morningstar
Credit Suisse
Cowen
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
220.54USD
Average target price
250.73USD
Spread / Average Target
+13.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAH Stock
  4. Consensus Cardinal Health, Inc.